Microdose GLP-1 Injections
Price range: $125.00 through $199.00
Initial charge of $34 for consult, price of medication(s) charged upon consult approval.
A precision-dosed GLP-1 protocol designed for cardiometabolic and cellular impact—supporting insulin sensitivity, vascular metrics, brain health, and metabolic efficiency. Built to stack seamlessly with longevity and performance programs.
Microdose GLP-1 is a lower-dose, precisely timed GLP-1 protocol designed to influence appetite signaling, post-meal glucose, and autonomic steadiness without the large weekly swings associated with traditional high-dose weight-loss regimens.
Rather than centering on dramatic scale changes, this program is oriented around cardiometabolic and longevity metrics—the trends you track over months and years:
- Insulin sensitivity and post-meal glucose
- Lipids and blood-pressure patterns
- Inflammation balance
- Neurocognitive and autonomic trends (focus, HRV, sleep quality)
It’s intentionally designed to stack with broader longevity and performance programs, including peptides, hormone optimization, and targeted lifestyle frameworks.
Microdose GLP-1 is a prescription treatment available only after a full evaluation with a Wellcore provider.
Microdose GLP-1 uses glucagon-like peptide-1 (GLP-1) signaling with a different dosing rhythm:
GLP-1 pathway (what it does):
- Modulates appetite and satiety signaling in the brain
- Supports post-meal glucose control and smoother insulin response
- Slows gastric emptying to stabilize how you feel after meals
- Helps regulate autonomic steadiness—how your system responds to food, stress, and sleep
Microdosed, not mega-dosed:
- Uses smaller doses (e.g., 0.5 mL) administered once per week
- Aims for steady, gentle GLP-1 exposure instead of sharp weekly peaks
- Pairs the molecule with timing, nutrition, and recovery strategies to emphasize cardiometabolic and cellular health
Instead of positioning GLP-1 as a crash diet tool, the microdose protocol is engineered as a precision longevity instrument—supporting the internal metrics that predict long-term healthspan.
Microdose GLP-1 is for people who care less about “before/after” photos and more about what their labs, wearables, and brain feel like over time.
Built for modern longevity goals
- Focused on insulin sensitivity, lipids, vascular health, and brain aging, not just weight
- Designed to stack with longevity and performance programs (NAD+, BPC-157, GHK-Cu, hormone optimization, etc.)
- Pairs GLP-1 with data-informed coaching from your Wellcore provider
Gentle, steady exposure
- Smaller, more frequent doses may provide smoother day-to-day experience
- Aims to reduce big weekly swings in appetite, energy, and GI sensation
- Supports “always-on” cardiometabolic support that fits training and life rhythms
Clinician-guided, at-home protocol
- Self-administered subcutaneous injections at home
- Dosing, cadence, and stack integration are personalized by a licensed provider
- Medication compounded by U.S.-licensed 503A pharmacies, where permitted
This program is designed for biohackers, high-performers, and longevity-focused adults who want to work on the internal dashboard—not chase crash weight loss.
You may be a good fit if you:
- Care about cardiometabolic and brain health markers (A1C, fasting glucose, lipids, HRV, blood pressure)
- Want smoother post-meal energy and appetite signals, not extreme appetite suppression
- Already invest in training, nutrition, recovery, and sleep, and want a GLP-1 protocol that respects that
- Are comfortable with 3x-per-week micro-injections as part of a broader longevity stack
- Understand that body composition changes are a secondary benefit, not the primary promise
Microdose GLP-1 is not for:
- Individuals seeking an aggressive, rapid weight-loss drug as a standalone solution
- Anyone with contraindications to GLP-1 therapy (your provider will screen for these)
- Those looking for a quick fix without engaging in lifestyle work
Final eligibility and treatment design are always determined by a Wellcore provider after a full clinical evaluation.
Your provider will give you exact dosing and timing instructions. A typical Wellcore microdose protocol:
- Dose: 0.3 mL per injection (microdose strength), as prescribed
- Frequency: Three times per week (for example: Monday / Wednesday / Friday), or as directed
- Route: Subcutaneous injection into the abdomen, thigh, or other approved sites
- Timing: Consistent timing on each injection day, often coordinated with nutrition and training patterns
General guidance:
- Rotate injection sites to reduce local irritation
- Follow your provider’s recommendations on meal timing and macro composition around injections
- Use your wearables (HRV, sleep, heart rate, etc.) and labs as feedback loops—share this data with your provider when possible
Never change your dose or schedule without consulting your Wellcore provider.
Complete Microdose GLP-1 Package
- Multi-dose vial(s) of compounded GLP-1 medication, calibrated for microdosing
- Syringes, needles, and alcohol swabs for subcutaneous administration
- Clear instructions for storage, handling, and injection technique
- Provider-defined microdose schedule and integration plan (nutrition, training, and stack alignment)
- Cold-packed, discreet shipment delivered to your door where permitted
- Access to the Wellcore clinical support team for questions, side-effect guidance, and metric-driven tune-ups
Contents may vary based on your prescription and pharmacy partner.
Your Treatment Journey
Start Your Online Evaluation
Get approved by provider
Receive Your product at Home
Start treatment with provider guidance
Is this for weight loss?
It can support body composition, but that’s not the primary aim. This protocol is built around cardiometabolic, vascular, and cognitive-adjacent metrics—things like A1C, fasting glucose, lipids, HRV, and daily steadiness. Think longevity and performance first; body composition second.
How often is it taken?
Microdose GLP-1 is typically taken three times per week (0.3 mL per injection) on a consistent cadence, as directed by your provider. The exact schedule can be tuned around your training, work, and sleep patterns.
Will I still feel hungry?
Most people notice smoother appetite and post-meal signals, not total shutdown of hunger. The goal is autonomic steadiness and better food decisions, not making you disinterested in eating altogether.
Can this stack with other longevity treatments?
Yes—when designed by your provider. Microdose GLP-1 is meant to stack with peptides, NAD+ programs, hormone optimization, and performance protocols. Always disclose your full stack (prescription, OTC, and supplements) so your provider can design safely.
How quickly will I notice changes?
Many notice steadier energy and appetite within the first 1–2 weeks. Over 3–6+ weeks, it’s common to see trends in glucose control, HRV, sleep quality, and day-to-day focus. Weight shifts may occur, but the long game is cardiometabolic and cellular support.
Is Microdose GLP-1 an FDA-approved regimen?
The GLP-1 molecule may be FDA-approved in certain branded forms, but microdosed, compounded GLP-1 protocols themselves are not FDA-approved. When provided via compounding, medication is prepared by U.S.-licensed 503A pharmacies under a provider’s prescription and used off-label where appropriate. Your provider will discuss FDA-approved alternatives as part of informed consent.
Do Not Use Microdose GLP-1 If You:
- Have a personal or family history of medullary thyroid carcinoma (MTC)
- Have multiple endocrine neoplasia syndrome type 2 (MEN 2)
- Are pregnant, planning to become pregnant, or breastfeeding
- Have had a serious allergic reaction to GLP-1–based medications
Use With Caution If You:
- Have a history of pancreatitis
- Have significant GI conditions (like gastroparesis)
- Have advanced kidney or liver disease
- Take medications that affect blood sugar, insulin, or gastric emptying
- Have complex cardiometabolic or endocrine conditions
Always share your full medical history, current medications, and supplement list with your provider before starting Microdose GLP-1.
Commonly Reported Side Effects:
- Mild nausea or digestive upset, especially as you adjust
- Sensation of fullness or early satiety
- Occasional bloating, constipation, or loose stool
- Mild headache or fatigue
- Injection-site redness or tenderness
Side effects are often transient and dose-dependent. Your provider may adjust your timing, nutrition strategy, or dose to improve tolerability. Seek immediate medical care for signs of a severe allergic reaction, severe abdominal pain, or any rapidly worsening symptoms.
These statements have not been evaluated by the Food and Drug Administration. Microdose GLP-1 Injections are not intended to diagnose, treat, cure, or prevent any disease. All information on this page is for educational purposes only and does not replace personalized medical advice from a qualified healthcare professional.
Additional Transparency for Compounded Medications
- Many GLP-1–based therapies and dosing strategies described here involve off-label or adjunctive use as determined by your provider.
- When compounded, Microdose GLP-1 is prepared using GLP-1 ingredients by FDA-registered, U.S.-licensed 503A compounding pharmacies, where available and clinically appropriate.
- Availability may vary by state and may change as regulations and clinical guidance evolve.
Wellcore does not practice medicine or provide direct medical care. All prescriptions, treatment decisions, and care plans are made independently by licensed healthcare providers using their professional judgment. Images and product depictions are for illustration only; actual packaging and supplies may vary.
*If you are interested in a prescription product, Wellcore will coordinate a telehealth visit with a licensed medical provider who will determine if you are an appropriate candidate based on your health profile and current standards of care. If approved, your prescription will be filled by one of our partner pharmacies unless you request a different pharmacy. All prescriptions are subject to provider discretion and clinical appropriateness.